Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindu.com -  Bindu Shajan Perappadan - Advocacy group questions Medanta MD Naresh Trehan's inclusion in panel on pharma marketing practices
Advocacy group questions Medanta MD Naresh Trehan's inclusion in panel on pharma marketing practices
The Hindu –

The Working Group on Access to Medicines and Treatments has raised concerns over including Dr. Naresh Trehan, chairman and managing director of Medanta, in a committee constituted on the Supreme Court's directions to examine the regulatory…

thehindu.com -  The Hindu Bureau - KSSP supports distribution of generic drugs for SMA patients in Keralam
KSSP supports distribution of generic drugs for SMA patients in Keralam
The Hindu –

Updated - October 25, 2026 01:27 pm IST - Kozhikode Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers The Kerala Sastra Sahitya Parishad (KSSP) has supported the Kerala Health Department's…

thehindubusinessline.com - Neuland Laboratories: Betting On New Growth Avenues
Neuland Laboratories: Betting On New Growth Avenues
BusinessLine –

The CDMO sub-segment within the pharma sector has proven to be a winner even in the current times of heightened volatility. Earlier this year, we highlighted the positive prospects of Neuland Laboratories, which has transformed into a CDMO-led…

marketbeat.com - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Stock Now Rated 'Moderate Buy' by Sell-Side Brokerages
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Stock Now Rated 'Moderate Buy' by Sell-Side Brokerages
MarketBeat –

Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) have received an average recommendation of 'Moderate Buy' from the fourteen brokerages that are currently covering the company, Marketbeat.com reports. One analyst has…

cnbc.com - Paulina Likos - Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are surging. How investors can play the new drug innovation boom
CNBC –

Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this year. And it's hardly alone – the sector is on a roll and looks poised for more gains. The iShares Biotechnology ETF (IBB) is up…

lionessofjudah.substack.com - Lioness of Judah Ministry - SHOCKING: Sasha Latypova Exposes the Government-Led DEATH CULT Behind COVID
SHOCKING: Sasha Latypova Exposes the Government-Led DEATH CULT Behind COVID
Exposing The Darkness –

Exposing The Darkness is a reader-supported publication. To support my work, please consider becoming a paid subscriber. One-time or recurring donations can be made through Ko-Fi: ⚡ What aren't they telling you? Please Join Exposing the…

marketbeat.com - 106,238 Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Sterling Capital Management LLC
106,238 Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Sterling Capital Management LLC
MarketBeat –

Sterling Capital Management LLC decreased its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 37.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange…

fool.com - Brendan Coffey - Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
The Motley Fool –

Income seekers and growth investors often choose between biotech pioneers and diversified pharmaceutical giants. Comparing Amgen (AMGN -1.79%) and Johnson & Johnson (JNJ -1.42%) reveals two distinct paths for healthcare investing in 2026. Amgen…

thehindu.com -  C Maya - What is the controversy over the spinal muscular atrophy drug in Keralam? Explained
What is the controversy over the spinal muscular atrophy drug in Keralam? Explained
The Hindu –

An initiative launched by Keralam government to make the treatment for Spinal Muscular Atrophy (SMA) accessible to more patients is now courting controversy. SMA is a rare, life-threatening genetic disorder that progressively weakens muscles…

marketbeat.com - 8,009 Shares of Astrazeneca Plc $AZN Purchased by Sowell Financial Services LLC
8,009 Shares of Astrazeneca Plc $AZN Purchased by Sowell Financial Services LLC
MarketBeat –

Sowell Financial Services LLC purchased a new position in Astrazeneca Plc (NYSE:AZN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 8,009…

marketbeat.com - argenex (NASDAQ:ARGX) Cut to 'Hold' at Wall Street Zen
argenex (NASDAQ:ARGX) Cut to 'Hold' at Wall Street Zen
MarketBeat –

argenex (NASDAQ:ARGX - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a 'buy' rating to a 'hold' rating in a research report issued to clients and investors on Sunday, Wall Street Zen reports. 2 Ways to Play the Big…

marketbeat.com - Best Pharmaceutical Stocks To Watch Today - October 24th
Best Pharmaceutical Stocks To Watch Today - October 24th
MarketBeat –

Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck & Co., Inc., Abbott Laboratories, Gilead Sciences, and Pfizer are the seven Pharmaceutical stocks to watch today…

marketbeat.com - BG Investment Services LLC Acquires 2,046 Shares of Vertex Pharmaceuticals Incorporated $VRTX
BG Investment Services LLC Acquires 2,046 Shares of Vertex Pharmaceuticals Incorporated $VRTX
MarketBeat –

BG Investment Services LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm…

marketbeat.com - 1,457 Shares of argenex SE $ARGX Purchased by BG Investment Services LLC
1,457 Shares of argenex SE $ARGX Purchased by BG Investment Services LLC
MarketBeat –

BG Investment Services LLC bought a new position in shares of argenex SE (NASDAQ:ARGX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund…

marketbeat.com - GSK PLC Sponsored ADR $GSK Stock Purchased by Mondrian Investment Partners LTD
GSK PLC Sponsored ADR $GSK Stock Purchased by Mondrian Investment Partners LTD
MarketBeat –

Mondrian Investment Partners LTD increased its stake in shares of GSK PLC Sponsored ADR (NYSE:GSK - Free Report) by 1.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The…

Receive a Daily briefing on Pharma Industry News

Get Started